Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
With a market cap of 170.81B, Abbott(ABT) trades at $98.70. The stock has a price-to-earnings ratio of 31.73 and currently yields dividends of 2.53%.
On 2026-10-08, Abbott(ABT) stock moved within a range of $97.62 to $99.37. With shares now at $98.70, the stock is trading +1.1% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 9.39M, compared to an average daily volume of 8.6M.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $135.13 and a low of $81.97.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $135.13 and a low of $81.97.
ABT News
If you only glanced at Abbott Laboratories’ headlines this year, the story looked constructive. Product launches, major diagnostics deals and raised guidance al...
Barclays initiated coverage of Abbott (ABT) with an Overweight rating and $120 price target The firm rolled out coverage of the medical suppliers and devices gr...
Abbott Laboratories recently received FDA approval for upgraded capabilities on its CardioMEMS HF System and began U.S. commercialization of SimpleScreen CRC, a...
Analyst ratings
81%
of 31 ratingsMore ABT News
Investing Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield Both Medtronic and Abbott have dropped in 2026, and those decline...
Abbott (ABT) announced U.S. FDA approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App. For...
Abbott Laboratories (ABT) just brought SimpleScreen CRC to the U.S. market, adding an FDA-approved, Medicare-covered blood test for colorectal cancer screening...
Rothschild & Co Redburn upgraded Abbott (ABT) to Buy from Neutral with a price target of $127, up from $119. The company’s acquisition of Exact Sciences has str...
As healthcare costs and procedure volumes continue to shift globally, investors must decide between two titans of the industry. Choosing between Abbott Laborato...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.